Loading insider details...
Latest Form 4 (Jul 17, 2026): Grant/Award of 650,000 IMRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | Immuneering Corp (IMRX) | Grant/Award | 650,000 | n/a |
| Jun 8, 2026 | Turn Therapeutics Inc. (TTRX) | Grant/Award | 95,000 | n/a |
| May 5, 2026 | Terns Pharmaceuticals, Inc. (TERN) | Tender of Shares | 40,503 | $2.15M |
| Jan 16, 2026 | Terns Pharmaceuticals, Inc. (TERN) | Grant/Award | 68,750 | n/a |
| Oct 10, 2025 | Turn Therapeutics Inc. (TTRX) | Grant/Award | 10,000 | n/a |
| Jun 30, 2025 | Terns Pharmaceuticals, Inc. (TERN) | Purchase | 5,000 | $19.6K |
| Jun 16, 2025 | Terns Pharmaceuticals, Inc. (TERN) | Purchase | 5,000 | $18.8K |
| Feb 25, 2025 | Terns Pharmaceuticals, Inc. (TERN) | Grant/Award | 750,000 | n/a |
| Sep 5, 2024 | Athira Pharma, Inc. (ATHA) | Grant/Award | 10,000 | $13.4K |
| Feb 16, 2024 | Athira Pharma, Inc. (ATHA) | Grant/Award | 280,000 | n/a |